Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Given Consensus Rating of “Buy” by Brokerages
Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have received a consensus recommendation of “Buy” from the five ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued ratings on the stock in […]
Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Get Free Report) have received a consensus recommendation of “Buy” from the five ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued ratings on the stock in […]
